RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE
SINGAPORE, November 20, 2022 /PRNewswire/ — RVAC Medicines Pte. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a dedicated healthcare asset management company headquartered in Singaporeand the Agency for Science, Technology and Research (A*STAR) today announced the signing of a Master Research Collaboration Agreement to jointly investigate and develop solutions to …
RVAC MEDICINES AND A*STAR TO DEVELOP mRNA PRODUCTION CAPACITIES IN SINGAPORE Read More »